Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiency

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2001-1326

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiency ; volume:5 ; number:1 ; day:13 ; month:5 ; year:2016 ; pages:1-18 ; date:12.2016
Clinical and translational medicine ; 5, Heft 1 (13.5.2016), 1-18, 12.2016

Creator: Tucker, Torry A.

Contributor: Jeffers, Ann
Boren, Jake
Quaid, Brandon
Owens, Shuzi
Koenig, Kathleen B.
Tsukasaki, Yoshikazu
Florova, Galina
Komissarov, Andrey A.
Ikebe, Mitsuo
Idell, Steven
SpringerLink (Online service)

DOI: 10.1186/s40169-016-0097-2

URN: urn:nbn:de:1111-201606094595

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Tucker, Torry A.
Jeffers, Ann
Boren, Jake
Quaid, Brandon
Owens, Shuzi
Koenig, Kathleen B.
Tsukasaki, Yoshikazu
Florova, Galina
Komissarov, Andrey A.
Ikebe, Mitsuo
Idell, Steven
SpringerLink (Online service)

Other Objects (12)

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial

Hochschulschrift

Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden

Bone Marrow Plasminogen Activator in Malignant Disease

Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy

Hochschulschrift

Urokinase-type plasminogen activator receptor in vascular calcification

Isolation and Properties of Human Vascular Plasminogen Activator

Influence of delivery on plasminogen activator inhibitor activity

Purification and Some Properties of Tissue Plasminogen Activator

Plasminogen Activator Release by Oral Contraceptives and Exercise

Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers

Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial

Hochschulschrift

Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden

Bone Marrow Plasminogen Activator in Malignant Disease

Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy

Hochschulschrift

Urokinase-type plasminogen activator receptor in vascular calcification

Isolation and Properties of Human Vascular Plasminogen Activator

Influence of delivery on plasminogen activator inhibitor activity

Purification and Some Properties of Tissue Plasminogen Activator

Plasminogen Activator Release by Oral Contraceptives and Exercise

Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers

Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial

Hochschulschrift

Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden

Bone Marrow Plasminogen Activator in Malignant Disease

Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy

Hochschulschrift

Urokinase-type plasminogen activator receptor in vascular calcification

Isolation and Properties of Human Vascular Plasminogen Activator

Influence of delivery on plasminogen activator inhibitor activity

Purification and Some Properties of Tissue Plasminogen Activator

Plasminogen Activator Release by Oral Contraceptives and Exercise

Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers

Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiency

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial

Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden

Bone Marrow Plasminogen Activator in Malignant Disease

Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy

Urokinase-type plasminogen activator receptor in vascular calcification

Isolation and Properties of Human Vascular Plasminogen Activator

Influence of delivery on plasminogen activator inhibitor activity

Purification and Some Properties of Tissue Plasminogen Activator

Plasminogen Activator Release by Oral Contraceptives and Exercise

Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers

Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial

Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden

Bone Marrow Plasminogen Activator in Malignant Disease

Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy

Urokinase-type plasminogen activator receptor in vascular calcification

Isolation and Properties of Human Vascular Plasminogen Activator

Influence of delivery on plasminogen activator inhibitor activity

Purification and Some Properties of Tissue Plasminogen Activator

Plasminogen Activator Release by Oral Contraceptives and Exercise

Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers

Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial

Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden

Bone Marrow Plasminogen Activator in Malignant Disease

Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy

Urokinase-type plasminogen activator receptor in vascular calcification

Isolation and Properties of Human Vascular Plasminogen Activator

Influence of delivery on plasminogen activator inhibitor activity

Purification and Some Properties of Tissue Plasminogen Activator

Plasminogen Activator Release by Oral Contraceptives and Exercise

Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers

Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)

Related objects

Reset password